| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | HANNAH ALISON L. | Chief Medical Officer | Jul 20, 2022 | Sale | $1.42 | 5,602 | 7,965 | 31,898 | Jul 21, 2022, 04:09 PM | |
| NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Aug 06, 2020 | Option Exercise | $7.27 | 10,000 | 72,700 | 88,796 | Aug 10, 2020, 06:22 PM | |
| NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Sep 09, 2019 | Option Exercise | $8.41 | 11,666 | 98,111 | 76,098 | Sep 11, 2019, 08:00 PM | |
| NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Aug 09, 2017 | Option Exercise | $6.66 | 6,667 | 44,402 | 45,449 | Oct 03, 2017, 05:19 PM | |
| NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Jul 27, 2017 | Buy | $9.19 | 20,000 | 183,800 | 38,782 | Jul 31, 2017, 05:25 PM | |
| NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Apr 20, 2016 | Option Exercise | $7.15 | 2,150 | 15,373 | 13,710 | May 04, 2016, 08:14 PM | |
| NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Mar 03, 2016 | Buy | $6.90 | 10,000 | 69,000 | 11,560 | Mar 04, 2016, 04:31 PM |
Menu